Telomir Pharmaceuticals, Inc. - TELO

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 19
Latest filed: Jul 27, 2026
Form Count
8-K 10
4 8
SCHEDULE 13G/A 1

Latest files

Filed Form Report period Accession SEC
Jul 27, 2026 4 Apr 16, 2026 0001493152-26-034811 View
Jul 27, 2026 4 Apr 16, 2026 0001493152-26-034812 View
Jul 27, 2026 4 Apr 16, 2026 0001493152-26-034813 View
Jun 15, 2026 8-K Jun 15, 2026 0001493152-26-028614 View
Jun 08, 2026 8-K Jun 03, 2026 0001493152-26-027752 View
May 22, 2026 4 May 21, 2026 0001493152-26-025113 View
May 22, 2026 4 May 21, 2026 0001493152-26-025114 View
May 22, 2026 4 May 21, 2026 0001493152-26-025115 View
May 22, 2026 4 May 21, 2026 0001493152-26-025116 View
May 20, 2026 8-K May 20, 2026 0001493152-26-024517 View
Apr 30, 2026 8-K Apr 24, 2026 0001493152-26-019773 View
Apr 24, 2026 4 Apr 22, 2026 0001493152-26-018911 View
Apr 24, 2026 8-K Apr 22, 2026 0001493152-26-018867 View
Mar 31, 2026 8-K Mar 31, 2026 0001493152-26-013785 View
Mar 31, 2026 8-K Mar 30, 2026 0001493152-26-013872 View
Mar 27, 2026 8-K Mar 23, 2026 0001493152-26-013240 View
Feb 17, 2026 8-K Feb 17, 2026 0001493152-26-006937 View
Feb 12, 2026 SCHEDULE 13G/A 0001104659-26-014568 View
Feb 05, 2026 8-K Feb 05, 2026 0001493152-26-005199 View